Accelerate Diagnostics, Inc. (AXDX)

NASDAQ: AXDX · IEX Real-Time Price · USD

1.150

-0.020 (-1.71%)

At close: Jul 2, 2024, 4:00 PM

1.120

-0.030 (-2.61%)

After-hours: Jul 2, 2024, 4:02 PM EDT

Accelerate Diagnostics Market Cap

Accelerate Diagnostics has a market cap or net worth of $25.36 million as of July 2, 2024. Its market cap has decreased by -62.60% in one year.

Market Cap

25.36M

Enterprise Value

50.02M

1-Year Change

-62.60%

Ranking

#4845

Market Cap Chart

Since December 1, 1998, Accelerate Diagnostics's market cap has increased from $21.70M to $25.36M, an increase of 16.86%. That is a compound annual growth rate of 0.61%.

Market Cap History

Date	Market Cap	% Change
Jul 1, 2024	25.80M	-54.74%
Dec 29, 2023	57.00M	-18.57%
Dec 30, 2022	70.00M	-79.56%
Dec 31, 2021	342.50M	-20.77%
Dec 31, 2020	432.30M	-53.19%
Dec 31, 2019	923.50M	48.16%
Dec 31, 2018	623.30M	-57.06%
Dec 29, 2017	1.45B	35.99%
Dec 30, 2016	1.07B	11.02%
Dec 31, 2015	961.40M	12.30%
Dec 31, 2014	856.10M	69.22%
Dec 31, 2013	505.90M	395.49%
Dec 31, 2012	102.10M	661.94%
Dec 30, 2011	13.40M	26.42%
Dec 31, 2010	10.60M	23.26%
Dec 31, 2009	8.60M	-63.40%
Dec 31, 2008	23.50M	-49.13%
Dec 31, 2007	46.20M	132.16%
Dec 29, 2006	19.90M	-34.32%
Dec 30, 2005	30.30M	44.98%
Dec 31, 2004	20.90M	-1.88%
Dec 31, 2003	21.30M	56.62%
Dec 31, 2002	13.60M	-16.05%
Dec 31, 2001	16.20M	575.00%
Dec 29, 2000	2.40M	-76.47%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
ImmunoPrecise Antibodies	27.10M
NRx Pharmaceuticals	26.97M
Acasti Pharma	26.69M
NeuroBo Pharmaceuticals	26.65M
Beyond Air	25.90M
Qilian International Holding Group	25.60M
Femasys	25.56M
bioAffinity Technologies	25.53M

Market Cap Rankings